Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Health Innovations Pharmacy is recalling Carvedilol 1.25 mg/mL due to quality control issues affecting sterility and stability data.
Akorn, Inc. is recalling specific lots of Sulfamethoxazole and Trimethoprim Oral Suspension because the sulfamethoxazole component failed to meet dissolution specifications.
Apotex Inc. is voluntarily recalling 6,467 units of Olanzapine 10 mg orally disintegrating tablets because the drug is subpotent.
Health Innovations Pharmacy is recalling Colchicine 0.6 mg capsules because inspection observations indicate a lack of assurance regarding sterility and stability data.
Health Innovations Pharmacy is recalling Nifedipine 0.2% - Lidocaine 2% Jelly due to sterility and stability concerns. The recall covers all lots distributed in North Carolina.
Akorn, Inc. is recalling 8,400 cups of Sulfamethoxazole and Trimethoprim oral suspension because the sulfamethoxazole failed to meet dissolution specifications.
Mission Pharmacal is recalling 1,992 kits of Sodium Sulfacetamide 9% and Sulfur 4.5% Wash due to microbial contamination.
Health Innovations Pharmacy is recalling DHEA 10 mg SR Capsules because inspection findings indicate a lack of assurance regarding sterility and stability data.
Health Innovations Pharmacy is recalling Phenylephrine 0.5% Solution due to quality control issues that present a risk to sterility and stability.
Cipla Limited is recalling 140,625 vials of Levalbuterol Inhalation Solution because the product failed impurity specifications. The affected lot is distributed nationwide.
Medtech Products, Inc. is recalling Monistat 1 Simple Cure because the distributed units lack the required topical cream.
Apotex Inc. is voluntarily recalling specific lots of Olanzapine 5 mg orally disintegrating tablets because they contain less active drug than labeled.
Apotex Inc. is voluntarily recalling 5,352 bottles of Olanzapine 20 mg tablets because the drug was found to be subpotent.
Physician Preferred Medical, LLC is recalling Epel 18 mg Estradiol Pellets because the specific lot failed sterility testing. The product was distributed in Arizona and Kansas.
Detox Transforms is recalling EDGE Amplified Weight Release capsules because the product contains undeclared phenolphthalein and fluoxetine, making it an unapproved drug.
Ultra ZX Labs is recalling Ultra ZX dietary supplements because FDA testing found undeclared sibutramine and phenolphthalein. The product was marketed without an approved NDA or ANDA.
The FDA is recalling iNSANE Bee Pollen capsules because they contain undeclared phenolphthalein and fluoxetine, making them unapproved drugs.
REFA Enterprises is recalling Forever Beautiful Bee Pollen capsules because FDA analysis found the product contains sibutramine and phenolphthalein.
REFA Enterprises is recalling Forever Beautiful INFINITY capsules because FDA analysis found the product contains sibutramine and phenolphthalein without an approved NDA/ANDA.
Anabolic Science Labs LLC is recalling Estrastain Pro-Anabolic Mass and Hardening Complex capsules because they contain unapproved synthetic hormone ingredients.
Anabolic Science Labs is recalling SWOLL-250 Super Mass Builder Quad Stack capsules because they contain unapproved synthetic hormone ingredients.
Detox Transforms is recalling AMPD GOLD Bee Pollen capsules because they contain undeclared sildenafil, making them unapproved drugs.
The FDA is recalling HALO-70 MEGA MASS BUILDER capsules because they contain an unapproved synthetic hormone ingredient, making them unapproved new drugs.
Detox Transforms is recalling iNDiGO capsules because they contain undeclared phenolphthalein, making the product an unapproved drug.
The FDA is recalling M14-Ment Advanced Mass Builder capsules because they contain an unapproved synthetic hormone ingredient, making them unapproved new drugs.